In 2005, Catherine joined the investment team of SVG Capital, a leading private equity firm based in London. During her tenure, she led numerous fund investments on a global basis across four investment platforms, representing over €3.5bn in over 100 fund commitments. Catherine was responsible for the due diligence process, investment decision and portfolio monitoring of the European portfolio. From 2011 onwards, she led the European Investment team and was responsible for the day-to-day operations of the Fund team in London. In addition, Catherine was actively involved in setting up the SVG Asian operations in 2008, contributing to building and training the team and spending a significant amount of time in the Singapore office until 2012.
When SVG Capital joined Aberdeen Asset Management (‘AAM’) in 2013, Catherine was a member of the Investment Committee of the newly formed Aberdeen SVG entity which oversaw €4.7bn of private equity assets. In that same year, Catherine was nominated for Financial News’s “40 under 40 Rising Stars in Private Equity” award. In 2015, she was part of the SVG Capital team that spun off from AAM. The SVG Capital Investment Trust was successfully sold the following year in a public takeover bid. In 2017, the departing team founded Larchpoint, a single-family office. Catherine was a Partner overseeing the management and the investment strategy and the European investment activity of the firm.
She was a member of the Investment Committee, approving US and European fund investments (more than 30 commitments during her tenure). As such, Catherine has an extensive network of GPs in particular in the UK and Scandinavia. Catherine holds an MA in Management from HEC, Paris, and is a CFA charterholder. Catherine Haumesser is director of ARMEN PARTNERS UK LIMITED, 100% subsidiary of Armen SAS. Catherine sits on the board of St Mark’s Hospital Foundation, which raises funds for research and education at the UK’s national bowel hospital.